Background Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Methods Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Results Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thrombotic events included 41 venous thromboembolism and 34 arterial thrombosis. Age, cardiovascular disease, intensive care unit treatment, white blood cells, D-dimer, albumin and troponin blood levels were associated with thrombotic events. In a multivariable regression logistic model, intensive care unit treatment (Odds Ratio [OR]: 6.0; 95% Confidence Interval [CI] 2.8-12.6; p < 0.001); coronary artery disease (OR: 2.4; 95% CI 1.4-5.0; p = 0.022); and albumin levels (OR: 0.49; 95% CI 0.28-0.87; p = 0.014) were associated with ischemic events. Age, sex, chronic obstructive pulmonary disease, diabetes, heart failure, coronary heart disease, intensive care unit treatment, in-hospital thrombotic events, D-dimer, C-reactive protein, troponin, and albumin levels were associated with mortality. A multivariable Cox regression analysis showed that in-hospital thrombotic events (hazard ratio [HR]: 2.72; 95% CI 1.59-4.65; p < 0.001), age (HR: 1.035; 95% CI 1.014-1.057; p = 0.001), and albumin (HR: 0.447; 95% CI 0.277-0.723; p = 0.001) predicted morality. Conclusions Covid-19 patients experience an equipollent rate of venous and arterial thrombotic events, that are associated with poor survival. Early identification and appropriate treatment of Covid-19 patients at risk of thrombosis may improve prognosis.

Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality / Violi, Francesco; Ceccarelli, Giancarlo; Cangemi, Roberto; Cipollone, Francesco; D'Ardes, Damiano; Oliva, Alessandra; Pirro, Matteo; Rocco, Monica; Alessandri, Francesco; D'Ettorre, Gabriella; Lichtner, Miriam; Pignatelli, Pasquale; Ferro, Domenico; Ruberto, Franco; Lip, Gregory Y H; Pugliese, Francesco; Mastroianni, Claudio Maria; Intensive Care, Infectious Diseases COVID-19 Study Group of Sapienza University. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - (2021). [10.1007/s11739-020-02621-8]

Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality

Violi, Francesco;Ceccarelli, Giancarlo;Cangemi, Roberto;Cipollone, Francesco;Oliva, Alessandra;Rocco, Monica;Alessandri, Francesco;D'Ettorre, Gabriella;Lichtner, Miriam;Pignatelli, Pasquale;Ferro, Domenico;Ruberto, Franco;Pugliese, Francesco;Mastroianni, Claudio Maria;
2021

Abstract

Background Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Methods Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Results Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thrombotic events included 41 venous thromboembolism and 34 arterial thrombosis. Age, cardiovascular disease, intensive care unit treatment, white blood cells, D-dimer, albumin and troponin blood levels were associated with thrombotic events. In a multivariable regression logistic model, intensive care unit treatment (Odds Ratio [OR]: 6.0; 95% Confidence Interval [CI] 2.8-12.6; p < 0.001); coronary artery disease (OR: 2.4; 95% CI 1.4-5.0; p = 0.022); and albumin levels (OR: 0.49; 95% CI 0.28-0.87; p = 0.014) were associated with ischemic events. Age, sex, chronic obstructive pulmonary disease, diabetes, heart failure, coronary heart disease, intensive care unit treatment, in-hospital thrombotic events, D-dimer, C-reactive protein, troponin, and albumin levels were associated with mortality. A multivariable Cox regression analysis showed that in-hospital thrombotic events (hazard ratio [HR]: 2.72; 95% CI 1.59-4.65; p < 0.001), age (HR: 1.035; 95% CI 1.014-1.057; p = 0.001), and albumin (HR: 0.447; 95% CI 0.277-0.723; p = 0.001) predicted morality. Conclusions Covid-19 patients experience an equipollent rate of venous and arterial thrombotic events, that are associated with poor survival. Early identification and appropriate treatment of Covid-19 patients at risk of thrombosis may improve prognosis.
2021
covid-19; mortality; sars-cov-2; thrombosis
01 Pubblicazione su rivista::01a Articolo in rivista
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality / Violi, Francesco; Ceccarelli, Giancarlo; Cangemi, Roberto; Cipollone, Francesco; D'Ardes, Damiano; Oliva, Alessandra; Pirro, Matteo; Rocco, Monica; Alessandri, Francesco; D'Ettorre, Gabriella; Lichtner, Miriam; Pignatelli, Pasquale; Ferro, Domenico; Ruberto, Franco; Lip, Gregory Y H; Pugliese, Francesco; Mastroianni, Claudio Maria; Intensive Care, Infectious Diseases COVID-19 Study Group of Sapienza University. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - (2021). [10.1007/s11739-020-02621-8]
File allegati a questo prodotto
File Dimensione Formato  
Violi_Arterial_ 2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 699.37 kB
Formato Adobe PDF
699.37 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1562564
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact